Form 8-K Sientra, Inc. For: Oct 23

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): October 23, 2015

 

 

SIENTRA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

420 South Fairview Avenue, Suite 200

Santa Barbara, CA 93117

(Address of Principal Executive Offices and Zip Code)

 

(805) 562-3500

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01.                                        Other Events.

 

On October 23, 2015, Sientra, Inc. (the “Company”) issued a press release regarding the manufacturing facilities of Silimed, the Company’s contract manufacturer. A copy of the press release is filed as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01.                                        Financial Statements and Exhibits.

 

(d)                                 Exhibits

 

Exhibit No.		Description
99.1		Press Release of Sientra, Inc. dated October 23, 2015.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

 

	SIENTRA, INC.
Dated: October 23, 2015	By:	/s/ Hani Zeini
		Hani Zeini
		President and Chief Executive Officer

 

3

 

INDEX TO EXHIBITS

 

Exhibit No.		Description
99.1		Press Release of Sientra, Inc. dated October 23, 2015.

 

4

Exhibit 99.1

 

 

Sientra Issues Statement Regarding Silimed Manufacturing Facilities

 

SANTA BARBARA, Calif., October 23, 2015 — Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today issued the following statement regarding a recent development at Silimed’s manufacturing facilities:

 

We are aware of a fire in one of the two manufacturing buildings at Silimed, and are in contact with Silimed in order to assess the situation. Our thoughts are with the entire Silimed team. Our management team is working diligently to get answers and we will share additional information when it is available.

 

About Sientra

 

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products.

 

Contact

 

Investor Contacts:

The Ruth Group

Nick Laudico

(646) 536-7030

[email protected]

 

Media Contacts:

Joele Frank, Wilkinson Brimmer Katcher

Daniel Katcher / Kelly Sullivan / Alyssa Cass

(212) 355-4449

 

###